Hospitalized patients with cirrhosis have a high rate of mortality. In the report by Bajajet al., the negative impact of fungal infections (FI) on outcomes in a large US cohort of hospitalized cirrhotics is highlighted. Risk factors for FI are identified. Increasing awareness of FI along with the application of new diagnostic tools in species identification will provide the opportunity to improve patient outcomes.
1Department of Medicine, Division of Infectious Disease, Mayo Clinic, Jacksonville, Florida, USA
2Department of Transplant, Mayo Clinic, Jacksonville, Florida, USA
Correspondence: Andrew P. Keaveny, MD, FRCPI, FAASLD, Department of Transplant, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224, USA. E-mail: email@example.com
Received 1 January 2018; accepted 5 January 2018